238120 — Aligned Genetics Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for Aligned Genetics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7,957	11,762	13,753	15,215	15,778
Cost of Revenue
Gross Profit	4,543	7,347	8,766	10,670	11,155
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	8,211	9,583	10,904	11,878	12,998
Operating Profit	-253	2,179	2,849	3,337	2,780
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	468	3,813	2,442	3,424	4,542
Provision for Income Taxes
Net Income After Taxes	468	5,542	2,333	3,236	4,128
Net Income Before Extraordinary Items
Net Income	468	5,542	2,333	3,236	4,128
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	468	5,542	2,333	3,236	4,128
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	32.6	385	162	227	287
Dividends per Share